Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Details for Australian Patent Application No. 2011202162 (hide)

Owner Watson Pharmaceuticals, Inc.

Inventors Nangia, Avinash; Kositprapa, Unchalee; Goldfarb, Robert I.; Cardinal, John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2011202162

Parent 2004283059

Filing date 10 May 2011

Wipo publication date 2 June 2011

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/425 (2006.01) - Thiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

26 May 2011 Complete Application Filed

2 June 2011 Application Open to Public Inspection

  Published as AU-A-2011202162

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202163-Method and apparatus for injecting a gas into a two-phase stream

2011202161-Power meter phase identification